BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25948131)

  • 1. Statin-associated muscle injury.
    Ballard KD; Taylor BA; Thompson PD
    Eur J Prev Cardiol; 2015 Sep; 22(9):1161. PubMed ID: 25948131
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular Effects of Rocuronium Bromide in Patients in Statin Therapy for at least Three Months.
    Ren H; Lv H
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):582-587. PubMed ID: 27234897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations.
    Panza GA; Taylor BA; Dada MR; Thompson PD
    J Clin Lipidol; 2015; 9(3):351-6. PubMed ID: 26073393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms.
    Taylor BA; Panza G; Thompson PD
    Int J Cardiol; 2016 Apr; 209():12-3. PubMed ID: 26874453
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights Into Statin Intolerance.
    Kopecky S; Baum S; Foody JM; Koren M; McKenney J; Sperling L; Wong ND;
    Clin Cardiol; 2015 Sep; 38(9):520-6. PubMed ID: 26337173
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2015 Feb; 238(2):329-35. PubMed ID: 25545331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in muscle strength in patients with statin myalgia.
    Panza GA; Taylor BA; Roman W; Thompson PD
    Am J Cardiol; 2014 Oct; 114(8):1215-6. PubMed ID: 25171803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated necrotising myopathy linked to statin use.
    Kipfer S; Frigerio S; Hench J; Aussy A; Boyer O
    Lancet; 2015 Oct; 386(10005):e26. PubMed ID: 26074381
    [No Abstract]   [Full Text] [Related]  

  • 9. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-induced necrotizing autoimmune myopathy: importance of early recognition.
    Hussenbux A; Hofer M; Steuer A
    Br J Hosp Med (Lond); 2017 Jun; 78(6):352-353. PubMed ID: 28614015
    [No Abstract]   [Full Text] [Related]  

  • 11. Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin.
    Camerino GM; De Bellis M; Conte E; Liantonio A; Musaraj K; Cannone M; Fonzino A; Giustino A; De Luca A; Romano R; Camerino C; Laghezza A; Loiodice F; Desaphy JF; Conte Camerino D; Pierno S
    Toxicol Appl Pharmacol; 2016 Sep; 306():36-46. PubMed ID: 27377005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
    Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathy associated with statin therapy.
    Hilton-Jones D
    Neuromuscul Disord; 2008 Jan; 18(1):97-8. PubMed ID: 17892936
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.
    Elam MB; Majumdar G; Mozhui K; Gerling IC; Vera SR; Fish-Trotter H; Williams RW; Childress RD; Raghow R
    PLoS One; 2017; 12(8):e0181308. PubMed ID: 28771594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats.
    El-Ganainy SO; El-Mallah A; Abdallah D; Khattab MM; Mohy El-Din MM; El-Khatib AS
    Toxicol Lett; 2017 Jan; 265():23-29. PubMed ID: 27815113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.
    Calza L; Magistrelli E; Colangeli V; Borderi M; Contadini I; Bon I; Re MC; Viale P
    AIDS; 2017 Mar; 31(5):681-688. PubMed ID: 28060020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Treatment Decreases Mitochondrial Respiration But Muscle Coenzyme Q10 Levels Are Unaltered: The LIFESTAT Study.
    Dohlmann TL; Morville T; Kuhlman AB; Chrøis KM; Helge JW; Dela F; Larsen S
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2501-2508. PubMed ID: 30299473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance.
    Ballard KD; Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
    Atherosclerosis; 2013 Sep; 230(1):121-4. PubMed ID: 23958263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STOMPing forward: statins, muscle complaints and CK.
    Laaksonen R
    Atherosclerosis; 2013 Oct; 230(2):256-7. PubMed ID: 24075753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.